Role of Chemotherapy in Hormone-Refractory Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|70|1|1-14

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.70, Iss.1, 2003-02, pp. : 1-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TREATMENT WITH PREDNISOLONE OF HORMONE-REFRACTORY PROSTATE CANCER

By Fuse H.   Nozaki T.   Fujiuchi Y.   Mizuno I.   Nagakawa O.   Okumura A.  

Archives of Andrology, Vol. 52, Iss. 1, 2006-01 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite

Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer

By Yasufuku Tomihiko   Shigemura Katsumi   Matsumoto Osamu   Arakawa Soichi   Fujisawa Masato  

Journal of Infection and Chemotherapy, Vol. 16, Iss. 3, 2010-06 ,pp. : 200-205

Springer Publishing Company

Access to resources Recommend Favorite

Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital

By  

Urologia Internationalis, Vol. 83, Iss. 4, 2009-12 ,pp. : 452-457

Karger

Access to resources Recommend Favorite

REDISTRIBUTION OF ANDROGEN RECEPTORS IN ACQUIRED HORMONE-REFRACTORY PROSTATE CANCER CELLS

By Yu D. S.   Hsieh D. S.   Chang S. Y.  

Archives of Andrology, Vol. 52, Iss. 5, 2006-09 ,pp. : 389-395

Informa Healthcare

Access to resources Recommend Favorite

A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 281-287

Karger

Access to resources Recommend Favorite